BRAF and colorectal carcinoma: Those specific clinical features support the hypothesis that BRAF-mediated carcinogenesis in CRC commences with changes in the function of the BRAF gene as an initial step in the serrated pathway, which ultimately prompts RAF–MEK–ERK–MAP signaling activity [29].